Introducing HeartFlow PCI Navigator
HeartFlow, Inc. (NASDAQ: HTFL), a pioneer in AI technology for coronary artery disease, has launched an innovative tool called PCI Navigator. This integrated planning tool is designed specifically for interventional cardiologists, providing a patient-specific 3D model that details crucial aspects like anatomy, plaque composition, and lesion-specific physiology. With this technology, for the first time, cardiologists can access and analyze comprehensive information prior to procedures, significantly enhancing the planning process.
Enhancing PCI Planning with AI Insights
With PCI Navigator, doctors can streamline their decision-making process by viewing essential measurements seamlessly consolidated into one interface. This tool integrates advanced visualizations akin to IVUS and FFR, which previously required extensive preparation and time in the cath lab. This aids physicians in navigating complex procedures with enhanced clarity and confidence.
Live Demonstrations at Upcoming Conference
HeartFlow plans to showcase PCI Navigator at the Transcatheter Cardiovascular Therapeutics (TCT) conference, demonstrating its capabilities from October 25-28, 2025. The event will feature live demonstrations that highlight how this cutting-edge tool can revolutionize interventional cardiology.
Direct Advantages for Cardiologists
Interventional cardiologists often face immense pressure in making critical decisions with limited information. PCI Navigator addresses this by leveraging insights from the coronary computed tomography angiography (CCTA) pathway into a concrete pre-procedural plan. Dr. Campbell Rogers, Chief Medical Officer of HeartFlow, emphasized the potential of this technology to ensure all patients requiring invasive management can be properly assessed before entering the cath lab, thus improving overall efficiency and outcomes.
Key Features of PCI Navigator
PCI Navigator transforms how cardiologists approach patient care by offering a detailed synthesis of information needed to plan procedures effectively. Some of the standout features include:
- Procedural Complexity Analysis: Provides lesion-specific values that help elucidate the significance of lesions based on factors like stenosis and plaque composition.
- Stent Landing Zone Guidance: Supplies detailed reconstructions to aid clinicians in determining the optimal locations for stent placement, facilitating precise procedural guidance.
- Outcome Optimization Planning: Focuses on physiological changes along lesions to ensure that stenting procedures yield maximal blood flow recovery.
Insights from the PLAN CALCIUM Study
The upcoming conference will also feature findings from the PLAN CALCIUM Study, which explored the effectiveness of combining HeartFlow Plaque Analysis with coronary CTA imaging. Preliminary data suggest a significant impact of AI-driven plaque analysis on procedural decisions, particularly in managing highly calcified lesions. Over half of the cases assessed saw changes in plans for calcium modification, underscoring the increasing role of CT-guided planning in enhancing coronary interventions.
Future Initiatives: The NAVIGATE-PCI Registry
Looking ahead, HeartFlow is set to launch the NAVIGATE-PCI Registry in 2026, targeting the enrollment of over 2,500 patients across multiple sites in the U.S. This registry aims to evaluate the influence of PCI Navigator on various aspects such as physician confidence, procedural safety, and patient outcomes compared to traditional care methods.
A Commitment to Advancing Cardiac Care
HeartFlow’s commitment is not solely focused on technology, but extends to clinical excellence. Their methodologies abide by established guidelines and are backed by extensive research, including over 600 peer-reviewed publications. Their innovative data pipeline sourcing over 110 million annotated CTA images supports the accuracy of HeartFlow's solutions, making them reliable in real-world applications.
About HeartFlow, Inc.
HeartFlow is dedicated to changing the landscape of coronary artery disease management, leveraging AI to create actionable insights from coronary CTA images. Their mission revolves around enhancing detection and treatment efficiency, ensuring that medical professionals can provide the best care without resorting to invasive procedures.
Frequently Asked Questions
What is PCI Navigator?
PCI Navigator is an AI-driven planning tool designed for interventional cardiologists, providing a comprehensive 3D model of the coronary arteries for better pre-procedural insights.
How will PCI Navigator improve patient care?
By offering detailed anatomical and physiological information, PCI Navigator enhances planning accuracy, leading to improved patient outcomes and procedural efficiency.
Where can I see PCI Navigator in action?
HeartFlow will showcase PCI Navigator at the TCT conference, including live demonstrations highlighting the tool's capabilities and applications in interventional cardiology.
What is the NAVIGATE-PCI Registry?
The NAVIGATE-PCI Registry is a planned initiative that will enroll over 2,500 patients to evaluate PCI Navigator's impact on clinical practice and patient outcomes across the U.S.
How does HeartFlow validate its technology?
HeartFlow's solutions are validated through extensive clinical evidence, demonstrated reliability, and compliance with global security standards, ensuring patient data integrity.
